Two doctors at the National Cancer Centre Singapore (NCCS) have discovered a gene mutation in head and neck cancer patients that, for reasons as yet unknown, results in their responding well to a lung cancer drug.
At least one patient has survived a decade, instead of dying within a few months.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
